The Queen’s Speech has outlined the government’s legislative agenda for the coming year.
The United States has said it will support a proposal to waive intellectual property and patents on COVID-19 vaccines.
Ben Osborn, UK Country Manager of Pfizer, has been confirmed as the new President of the ABPI, beginning his term on 1 May.
The UK has announced that it will join the Ottawa Group’s Trade and Health Initiative, working towards enhanced global rules to facilitate trade in essential medical goods.
A £37 million investment for genomics projects and data-driven initiatives has been announced by the health secretary.
The UK government has launched a new Pandemic Preparedness Partnership to help save lives from future diseases and prevent another global pandemic.
NICE has launched its 5-year strategy which it says will help to speed up patients’ access to the latest and most effective treatments.
Reversing the impact of the coronavirus pandemic and improving long-term cancer outcomes is only possible if the entire UK cancer community comes together, says a new report.
The government has published its vision for the future of clinical research, setting out how it intends to capitalise on the successes of the past year.
The ABPI responded to Radio 4's File on Four programme on opioids, which examined whether there are any similarities between the way in which opioid medications are being marketed by pharmaceutical companies in the US and the UK.
The MHRA has updated their guidance for the batch testing of imported medicines following the end of the Brexit transition period.
